Ascentage Pharma Group International
AAPG
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.37B
Close$
Share Statistics
| Market cap | $1.37 Billion |
|---|---|
| Enterprise Value | $1.64 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-13.56 |
| Beta | 0.66 |
| Outstanding Shares | 93,312,054 |
Return
| Return on Equity | -468.36% |
|---|---|
| Return on Assets | -80.41% |
| Return on Invested Capital | -184.55% |
Valuation & Multiples
| P/E Ratio | -6.32 |
|---|---|
| PEG | -17.21 |
| Price to Sales | 1.49 |
| Price to Book Ratio | 2.49 |
| Enterprise Value to Revenue | 1.6 |
| Enterprise Value to EBIT | -0.65 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.32 |
| Debt to Equity | 3.89 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$53.63 M
Average shareholder expectationNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
$49.77 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 0.02% |
|---|---|
| Total Invested | $263,505▼ 63.49% |
| Investors Holding | 7▲ 1.00% |
ESG Score
No data
About Ascentage Pharma Group International
767 employees
CEO: Dajun Yang Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical cond...